CN113197970A - Blood sugar reducing composition, tea bag and preparation method thereof - Google Patents
Blood sugar reducing composition, tea bag and preparation method thereof Download PDFInfo
- Publication number
- CN113197970A CN113197970A CN202110612239.4A CN202110612239A CN113197970A CN 113197970 A CN113197970 A CN 113197970A CN 202110612239 A CN202110612239 A CN 202110612239A CN 113197970 A CN113197970 A CN 113197970A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood sugar
- tea bag
- raw materials
- sugar reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Diabetes (AREA)
- Insects & Arthropods (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of hypoglycemic medical treatment, and in particular relates to a hypoglycemic composition, a teabag and a preparation method thereof. The formula of the invention is used in mutual reinforcement, has the effects of clearing away heart-fire, reducing pathogenic fire, nourishing yin, clearing heat, nourishing yin, tonifying kidney, increasing body fluid and promoting the production of body fluid, can effectively improve the glucose metabolism index of a diabetic, and has certain curative effect on the type 2 diabetic. The formula provided by the invention is prepared into a tea bag form, is simple to prepare and convenient to eat, and is favorable for popularization and use as a health-care tea drink.
Description
Technical Field
The invention relates to the technical field of hypoglycemic medical treatment, in particular to a hypoglycemic composition, a teabag and a preparation method thereof.
Background
The chinese guidelines for the prevention and treatment of type 2 diabetes (2017) indicate that diabetes as a long-term chronic disease is controlled by systemic management rather than by traditional treatment. When the blood sugar can not be controlled to reach the standard by a single life style, the planned drug treatment is started, the first choice of the drug is metformin, and finally, the multiple injections of insulin are carried out.
Therefore, on the basis of the scheme for treating the diabetes, the treatment scheme of the traditional Chinese medicine is lacked, and the research and development of the traditional Chinese medicine formula can fill the part of the lacuna and can also be used as a conditioning means to realize the systematic management, thereby preventing and treating the diabetes.
Diabetes is called diabetes in the traditional Chinese medicine, and diabetes is a disease characterized by polydipsia, polyphagia, diuresis, emaciation and sweet urine. The traditional Chinese medicine considers that the causes of the disease are improper diet, emotional disorder, overstrain and kidney injury, etc., as explained in the book of Wai Tai Mi Yao & Xiao Ke Shen Xiao, ancient and modern Ling Xia: diabetes is also marked by thirst with much water, frequent urination, fat and sweetness similar to bran. The dialectical treatment is the essence of the traditional Chinese medicine for treating diabetes, the pattern of treating diabetes by typing in the upper, middle and lower triple energizers is formed when the diabetes is transported to the Song Dynasty, and a dialectical method for treating diabetes by three kinds of diabetes is generated. With the continuous development of traditional Chinese medicine, the understanding of modern traditional Chinese medicine on diabetes mellitus is more and more deeply taken as the concept of 'three-component elimination' treatment, and the concept is gradually replaced by the theory of visceral syndrome differentiation, so that the theory is more in line with clinical practice; the traditional Chinese medicine considers that the causes of diabetes are mainly caused by deficiency of body yin, improper diet, emotional disorder and excessive desire, the pathogenesis of the diabetes is heat accumulation and yin impairment, lung, spleen and kidney viscera loss, and the pathogenesis key points are as follows: (1) yin deficiency is the root cause and dryness-heat is the secondary cause. Dryness-heat is different from yin deficiency with internal heat, and when there is excess of pathogenic qi, it can clear heat; while yin deficiency is internal heat, even if internal heat is worse, yin is used as the main herb to supplement heat, while dryness heat is an excess heat syndrome different from heat in qi system, because yin deficiency is accompanied by pungent cold herbs, yin deficiency and dryness heat are causal, and yin deficiency is more deficient and dryness heat is more severe; (2) deficiency of both qi and yin is mainly spleen qi deficiency, and clinical patients mostly have symptoms such as fatigue, hypodynamia, short breath, spontaneous perspiration and the like, so the treatment principle is that heat clearing and detoxifying, middle-jiao and qi tonifying, yin nourishing and kidney tonifying are performed for conditioning treatment according to the clinical manifestations of diabetes mellitus, namely spleen qi deficiency and yin yang deficiency, thereby achieving the purpose of treatment. Therefore, the traditional Chinese medicine for treating diabetes has rationality in theory and clinic.
Disclosure of Invention
In order to overcome the defects and shortcomings in the prior art, the invention aims to provide a hypoglycemic composition, a tea bag and a preparation method thereof.
The purpose of the invention is realized by the following technical scheme:
the hypoglycemic composition comprises the following raw materials in parts by weight:
20-40 parts of cortex lycii radicis
10-20 parts of crouching Chinese brake herb
10-20 parts of rhizoma alismatis
7-11 parts of stiff silkworm
7-11 parts of lightyellow sophora root
5-9 parts of gallnut
5-9 parts of dwarf lilyturf tuber
4-8 parts of indigo naturalis.
The medicine property mechanism of each medicine of the invention is as follows:
cortex lycii radicis: the Chinese wolfberry bark is the root bark of Lycium chinense Mill of Solanaceae, has the effects of reducing fever and removing steaming, cooling blood and removing steaming, clearing lung-heat and reducing internal heat when being used as a medicine, and has the main chemical components including alkaloid, flavone, anthraquinone, lignan, organic acid and the like, and the components have the activities of reducing blood pressure, blood sugar, blood fat, bacteria and virus, and the like.
Laying the Chinese sage: has pungent and mild nature and taste, and has effects of clearing heat, removing toxic substance, promoting urination, cooling blood, stopping bleeding, invigorating qi, etc.;
rhizoma alismatis: sweet and light taste, cold in nature; entering kidney and bladder meridians; has the effects of promoting diuresis, eliminating dampness, clearing away heat, eliminating turbid pathogen, reducing blood lipid, etc.;
stiff silkworm: salty and pungent in flavor and mild in nature; it enters liver, lung and stomach meridians; has the effects of calming endogenous wind, relieving spasm, dispelling pathogenic wind, relieving pain, eliminating phlegm, and resolving masses; it is commonly used for treating liver wind with phlegm, convulsive epilepsy, convulsion, infantile convulsion, tetanus, apoplexy, wry mouth, wind-heat headache, conjunctival congestion, pharyngalgia, rubella pruritus, and parotitis;
flavescent sophora root: bitter taste and cold nature; the channels of heart, liver, stomach, large intestine and bladder; has the functions of clearing heat, drying dampness, killing parasites and promoting urination; it is commonly used for treating dysentery with fever, hematochezia, jaundice, anuria, leucorrhea with reddish discharge, vulval swelling, pruritus vulvae, eczema, skin pruritus, scabies, tinea, leprosy, and trichomonas vaginitis by external application;
gallnut: sour, astringent and cold in nature; entering lung, large intestine and kidney meridians; has the effects of astringing lung, reducing pathogenic fire, relieving diarrhea with astringents, arresting sweating, stopping bleeding, astringing dampness and healing sore; it is commonly used for chronic cough due to lung deficiency, chronic diarrhea and dysentery due to lung heat, spontaneous perspiration and night sweat, diabetes, hemafecia and hemorrhoidal bleeding, traumatic hemorrhage, carbuncle, swelling, sore and toxin, and skin wet and rot;
radix ophiopogonis: sweet, slightly bitter and slightly cold. Entering heart, lung and stomach meridians; has the effects of nourishing yin, promoting the production of body fluid, moistening lung and relieving cough; it is commonly used for treating scanty body fluid, thirst, dry cough and hemoptysis due to lung-stomach yin deficiency; palpitation due to heart yin deficiency and body fluids injured by heat in the late stage of fever;
indigo naturalis: salty and cold; entering liver meridian; has the effects of clearing away heat and toxic materials, cooling blood, removing speckle, purging pathogenic fire, and arresting convulsion; it is mainly used for treating epidemic febrile disease with excessive heat, macula, hematemesis, hemoptysis, pharyngalgia, aphtha, infantile convulsion, sore, swelling, erysipelas, snake and insect bite, etc.
Preferably, the hypoglycemic composition comprises the following raw materials in parts by weight:
25-35 parts of cortex lycii radicis
13-17 parts of crouching Chinese brake herb
13-17 parts of alisma orientale
8-10 parts of stiff silkworm
8-10 parts of sophora flavescens
6-8 parts of gallnut
Radix ophiopogonis 6-8 parts
And 5-7 parts of indigo naturalis.
Preferably, the hypoglycemic composition comprises the following raw materials in parts by weight:
cortex lycii radicis 30 parts
Laying herb 15 parts
15 portions of alisma orientale
Bombyx Batryticatus 9 parts
9 portions of lightyellow sophora root
Chinese gall 7 parts
Dwarf lilyturf tuber 7 parts
And 6 parts of indigo naturalis.
Preferably, the hypoglycemic composition comprises the following raw materials in parts by weight:
20-30 parts of cortex lycii radicis
10-15 parts of crouching Chinese brake herb
10-15 parts of rhizoma alismatis
9-11 parts of stiff silkworm
8-10 parts of sophora flavescens
6-7 parts of gallnut
Radix ophiopogonis 6-7 parts
4-8 parts of indigo naturalis.
Preferably, the hypoglycemic composition comprises the following raw materials in parts by weight:
cortex lycii radicis 30-40 parts
15-20 parts of crouching Chinese brake herb
15-20 parts of rhizoma alismatis
7-8 parts of stiff silkworm
7-8 parts of sophora flavescens
5-7 parts of gallnut
5-7 parts of dwarf lilyturf tuber
4-6 parts of indigo naturalis
Preferably, the blood sugar reducing composition also comprises 10-20 parts of cyclocarya paliurus, and the cyclocarya paliurus also has the blood sugar reducing effect, so that the tea flavor of the tea bag can be improved, and the flavor is better.
The invention also provides a blood sugar reducing teabag which comprises a tea bag and the blood sugar reducing composition arranged in the tea bag.
Wherein each tea bag is filled with 50-60g of the hypoglycemic composition.
The invention also provides a preparation method of the blood sugar reducing tea bag, which comprises the following steps: weighing the raw materials according to the blood sugar reducing composition, grinding and crushing the raw materials into 60-80 meshes, and filling the crushed raw materials into tea bags to obtain the blood sugar reducing tea bags.
The invention has the beneficial effects that:
the formula of the invention is used in mutual reinforcement, has the effects of clearing away heart-fire, reducing pathogenic fire, nourishing yin, clearing heat, nourishing yin, tonifying kidney, increasing body fluid and promoting the production of body fluid, can effectively improve the glucose metabolism index of a diabetic, and has certain curative effect on the type 2 diabetic.
The formula provided by the invention is prepared into a tea bag form, is simple to prepare and convenient to eat, and is favorable for popularization and use as a health-care tea drink.
Detailed Description
The present invention will be further described with reference to the following examples for facilitating understanding of those skilled in the art, and the description of the embodiments is not intended to limit the present invention.
Example 1
The hypoglycemic composition comprises the following raw materials in parts by weight:
cortex lycii radicis 30 parts
Laying herb 15 parts
15 portions of alisma orientale
Bombyx Batryticatus 9 parts
9 portions of lightyellow sophora root
Chinese gall 7 parts
Dwarf lilyturf tuber 7 parts
And 6 parts of indigo naturalis.
Preferably, the blood sugar reducing composition also comprises 15 parts of cyclocarya paliurus.
The invention also provides a blood sugar reducing teabag which comprises a tea bag and the blood sugar reducing composition arranged in the tea bag.
Wherein each tea bag is filled with 55g of the hypoglycemic composition.
The invention also provides a preparation method of the blood sugar reducing tea bag, which comprises the following steps: weighing the raw materials according to the blood sugar reducing composition, grinding and crushing the raw materials into 70 meshes, and filling the crushed raw materials into tea bags to obtain the blood sugar reducing tea bags.
75 subjects with type 2 diabetes were recruited and divided into 38 experimental groups and 37 control groups on a randomized basis, with 6 withdrawals, 2 withdrawals, 32 remaining experimental groups and 35 remaining control groups during the course of the experiment. The control group maintains the original living habits, the experimental group, while maintaining the original living habits, makes a bag of the blood sugar reducing tea bag every day, performs blood drawing detection on the fasting blood sugar concentration of the experimental subject before (0 month), 1 month and 3 months of the experiment respectively, and the detection results are as follows:
*: compared with a control group, the composition has no significant difference (P > 0.05).
Example 2
The hypoglycemic composition comprises the following raw materials in parts by weight:
20 portions of cortex lycii radicis
10 portions of lying egg grass
10 portions of alisma orientale
Bombyx Batryticatus 7 parts
7 portions of lightyellow sophora root
Chinese gall 5 parts
Radix Ophiopogonis 5 parts
And 4 parts of indigo naturalis.
Preferably, the blood sugar reducing composition also comprises 10 parts of cyclocarya paliurus.
The invention also provides a blood sugar reducing teabag which comprises a tea bag and the blood sugar reducing composition arranged in the tea bag.
Wherein each tea bag is filled with 50g of the hypoglycemic composition.
The invention also provides a preparation method of the blood sugar reducing tea bag, which comprises the following steps: weighing the raw materials according to the blood sugar reducing composition, grinding and crushing the raw materials into 60 meshes, and filling the crushed raw materials into tea bags to obtain the blood sugar reducing tea bags.
Example 3
The hypoglycemic composition comprises the following raw materials in parts by weight:
cortex lycii radicis 40 parts
20 parts of crouching Chinese brake herb
20 portions of alisma orientale
Bombyx Batryticatus 11 parts
11 portions of lightyellow sophora root
9 parts of Chinese gall
Radix Ophiopogonis 9 parts
8 parts of indigo naturalis.
Preferably, the blood sugar reducing composition also comprises 20 parts of cyclocarya paliurus.
The invention also provides a blood sugar reducing teabag which comprises a tea bag and the blood sugar reducing composition arranged in the tea bag.
Wherein each tea bag is filled with 60g of the hypoglycemic composition.
The invention also provides a preparation method of the blood sugar reducing tea bag, which comprises the following steps: weighing the raw materials according to the blood sugar reducing composition, grinding the raw materials into 80 meshes, and filling the powder into a tea bag to obtain the blood sugar reducing tea bag.
Example 4
The hypoglycemic composition comprises the following raw materials in parts by weight:
preferably, the hypoglycemic composition comprises the following raw materials in parts by weight:
20 portions of cortex lycii radicis
10 portions of lying egg grass
10 portions of alisma orientale
Bombyx Batryticatus 9 parts
8 portions of lightyellow sophora root
6 parts of Chinese gall
Radix Ophiopogonis 6 parts
And 4 parts of indigo naturalis.
Preferably, the blood sugar reducing composition also comprises 15 parts of cyclocarya paliurus.
The invention also provides a blood sugar reducing teabag which comprises a tea bag and the blood sugar reducing composition arranged in the tea bag.
Wherein, 555g of hypoglycemic composition is filled in each tea bag.
The invention also provides a preparation method of the blood sugar reducing tea bag, which comprises the following steps: weighing the raw materials according to the blood sugar reducing composition, grinding and crushing the raw materials into 70 meshes, and filling the crushed raw materials into tea bags to obtain the blood sugar reducing tea bags.
Example 5
The hypoglycemic composition comprises the following raw materials in parts by weight:
cortex lycii radicis 40 parts
20 parts of crouching Chinese brake herb
20 portions of alisma orientale
Bombyx Batryticatus 8 parts
8 portions of lightyellow sophora root
Chinese gall 7 parts
Dwarf lilyturf tuber 7 parts
Indigo naturalis 6 parts
Preferably, the blood sugar reducing composition also comprises 20 parts of cyclocarya paliurus.
The invention also provides a blood sugar reducing teabag which comprises a tea bag and the blood sugar reducing composition arranged in the tea bag.
Wherein each tea bag is filled with 55g of the hypoglycemic composition.
The invention also provides a preparation method of the blood sugar reducing tea bag, which comprises the following steps: weighing the raw materials according to the blood sugar reducing composition, grinding and crushing the raw materials into 70 meshes, and filling the crushed raw materials into tea bags to obtain the blood sugar reducing tea bags.
The above-described embodiments are preferred implementations of the present invention, and the present invention may be implemented in other ways without departing from the spirit of the present invention.
Claims (9)
1. A hypoglycemic composition characterized by: the feed comprises the following raw materials in parts by weight:
2. a hypoglycemic composition according to claim 1, wherein: the feed comprises the following raw materials in parts by weight:
3. a hypoglycemic composition according to claim 2, wherein: the feed comprises the following raw materials in parts by weight:
4. a hypoglycemic composition according to claim 1, wherein: the feed comprises the following raw materials in parts by weight:
5. a hypoglycemic composition according to claim 1, wherein: the feed comprises the following raw materials in parts by weight:
6. a hypoglycemic composition according to claim 1, wherein: also comprises 10-20 parts of cyclocarya paliurus.
7. A blood sugar reducing teabag is characterized in that: comprising a tea bag and the hypoglycemic composition of any one of claims 1 to 6 loaded in the tea bag.
8. The blood sugar reducing teabag according to claim 7, wherein: each tea bag is filled with 50-60g of hypoglycemic composition.
9. The method for preparing the blood sugar reducing teabag according to claim 7 or 8, wherein the method comprises the following steps: the hypoglycemic composition according to any one of claims 1-6, wherein the hypoglycemic tea bag is prepared by weighing the raw materials, grinding the raw materials into 60-80 meshes, and filling the crushed raw materials into a tea bag.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110612239.4A CN113197970A (en) | 2021-06-02 | 2021-06-02 | Blood sugar reducing composition, tea bag and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110612239.4A CN113197970A (en) | 2021-06-02 | 2021-06-02 | Blood sugar reducing composition, tea bag and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113197970A true CN113197970A (en) | 2021-08-03 |
Family
ID=77024063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110612239.4A Pending CN113197970A (en) | 2021-06-02 | 2021-06-02 | Blood sugar reducing composition, tea bag and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113197970A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895534A (en) * | 2006-06-18 | 2007-01-17 | 芮育健 | Diabetes treatment for clearing heat, relieving fire and nourishing Yin |
| CN101584371A (en) * | 2008-05-22 | 2009-11-25 | 李彦奎 | Health-care tea for nourishing yin, clearing away heat and reducing blood glucose for middle-old aged people |
| CN109224021A (en) * | 2018-10-29 | 2019-01-18 | 常现辉 | Treat diabetes, the health protecting tea of lowering blood pressure and blood fat and preparation method |
-
2021
- 2021-06-02 CN CN202110612239.4A patent/CN113197970A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895534A (en) * | 2006-06-18 | 2007-01-17 | 芮育健 | Diabetes treatment for clearing heat, relieving fire and nourishing Yin |
| CN101584371A (en) * | 2008-05-22 | 2009-11-25 | 李彦奎 | Health-care tea for nourishing yin, clearing away heat and reducing blood glucose for middle-old aged people |
| CN109224021A (en) * | 2018-10-29 | 2019-01-18 | 常现辉 | Treat diabetes, the health protecting tea of lowering blood pressure and blood fat and preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 汪悦等: "二地苦青汤治疗Ⅱ型糖尿病50例临床观察", 《辽宁中医学院学报》 * |
| 黄璐琦 等: "《神农架中药资源图志 第2卷》", 30 November 2018, 福建科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103690794A (en) | Traditional Chinese medicine preparation for treating diabetes mellitus | |
| CN101797326A (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
| CN101428113A (en) | Traditional Chinese medicine preparation for treating type II diabetes and preparation method thereof | |
| CN101745023B (en) | Compound bee product and preparation method thereof | |
| CN101406598B (en) | Chinese medicine composite for treating diabetes and preparation method thereof | |
| CN104856036B (en) | Health care medicated diet for treating iron-deficiency anemia and preparation method of health care medicated diet | |
| CN107737288B (en) | Traditional Chinese medicine composition for treating allergic asthma and preparation method thereof | |
| CN114404538B (en) | Traditional Chinese medicine composition for treating gouty arthritis and application thereof | |
| CN105497811A (en) | Traditional Chinese medicine composition for treating liver cirrhosis and preparation technology thereof | |
| CN104623314A (en) | Medicine composition for treating dry mouth and bitter taste and preparation method thereof | |
| CN113197970A (en) | Blood sugar reducing composition, tea bag and preparation method thereof | |
| CN1192789C (en) | 'Shenhuaxiaokecha' tea and preparing method thereof | |
| CN103239692B (en) | Chinese medicine liniment for treating skin itch and preparation method of Chinese medicine liniment | |
| CN104491621A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN104998158A (en) | Pharmaceutical composition for treating liver cirrhosis and application thereof | |
| CN104000932B (en) | A kind of Chinese medicine composition for the treatment of diabetes | |
| CN114848765B (en) | Traditional Chinese medicine composition for delaying progression of chronic kidney disease and application thereof | |
| CN115645493B (en) | Traditional Chinese medicine preparation for treating chronic kidney disease stage 3 and preparation method thereof | |
| CN117045764A (en) | Traditional Chinese medicine composition for treating type II diabetes and preparation method thereof | |
| CN105213975A (en) | A kind of pharmaceutical composition and application thereof for the treatment of liver cirrhosis | |
| CN105311413A (en) | Traditional Chinese medicinal composition containing folium artemisiae argyi for treating diabetic nephropathy and preparation method of traditional Chinese medicinal composition | |
| CN113769018A (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
| CN1090946C (en) | Traditional Chinese medicine for tonifying spleen and expelling dampness | |
| CN113876906A (en) | Pure traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
| CN104784567B (en) | A kind of pharmaceutical composition for the treatment of urinary system infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210803 |